InsiderTrades.com logo
Mai-Britt Zocca net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Mai-Britt Zocca Biography and Net Worth

Founder & CEO of IO Biotech

Dr. Zocca has served as our founder and Chief Executive Officer since January 2015. Dr. Zocca was also the founder and Chief Executive Officer of OncoNOx ApS, a pharmaceutical company, from July 2011 until May 2019. Prior to founding the Company, she was the Chief Executive Officer at LevOss ApS, a biotechnology company, from January 2012 until January 2017. Dr. Zocca also led DanDrit Biotech A/S, a biotechnology company, as its Chief Executive Officer from July 2007 until December 2010. Dr. Zocca currently serves on the board of directors for Dansk Biotek, a Danish biotechnology trade organization, and Valo Therapeutics Ltd., a biotechnology company. Dr. Zocca received her M.Sc in Biochemistry as well as Ph.D. in Medicine from the University of Copenhagen and NIH, NCI, MD, US.

What is Mai-Britt Zocca's net worth?

The estimated net worth of Mai-Britt Zocca is at least $2.39 thousand as of December 23rd, 2024. Dr. Zocca owns 49,891 shares of IO Biotech stock worth more than $2,395 as of October 9th. This net worth evaluation does not reflect any other assets that Dr. Zocca may own. Learn More about Mai-Britt Zocca's net worth.

How do I contact Mai-Britt Zocca?

The corporate mailing address for Dr. Zocca and other IO Biotech executives is , , . IO Biotech can also be reached via phone at 45-7070-2980 and via email at [email protected]. Learn More on Mai-Britt Zocca's contact information.

Has Mai-Britt Zocca been buying or selling shares of IO Biotech?

Mai-Britt Zocca has not been actively trading shares of IO Biotech during the past quarter. Most recently, on Monday, December 23rd, Mai-Britt Zocca bought 12,500 shares of IO Biotech stock. The stock was acquired at an average cost of $0.81 per share, with a total value of $10,125.00. Following the completion of the transaction, the chief executive officer now directly owns 49,891 shares of the company's stock, valued at $40,411.71. Learn More on Mai-Britt Zocca's trading history.

Who are IO Biotech's active insiders?

IO Biotech's insider roster includes Heidi Hunter (Director), Amy Sullivan (CFO), and Mai-Britt Zocca (Founder & CEO). Learn More on IO Biotech's active insiders.

Mai-Britt Zocca Insider Trading History at IO Biotech

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2024Buy12,500$0.81$10,125.0049,891View SEC Filing Icon  
See Full Table

Mai-Britt Zocca Buying and Selling Activity at IO Biotech

This chart shows Mai-Britt Zocca's buying and selling at IO Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IO Biotech Company Overview

IO Biotech logo
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.
Read More

Today's Range

Now: $0.05
Low: $0.05
High: $0.05

50 Day Range

MA: $0.08
Low: $0.03
High: $0.21

2 Week Range

Now: $0.05
Low: $0.03
High: $2.79

Volume

N/A

Average Volume

7,085,531 shs

Market Capitalization

$3.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88